These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 22000822)

  • 21. Subependymal giant cell astrocytoma: diagnosis, screening, and treatment. Recommendations from the International Tuberous Sclerosis Complex Consensus Conference 2012.
    Roth J; Roach ES; Bartels U; Jóźwiak S; Koenig MK; Weiner HL; Franz DN; Wang HZ
    Pediatr Neurol; 2013 Dec; 49(6):439-44. PubMed ID: 24138953
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optic nerve tumor in tuberous sclerosis complex is not responsive to sirolimus.
    Sparagana SP; Wilkes DC; Thompson CE; Bowers DC
    Pediatr Neurol; 2010 Jun; 42(6):443-6. PubMed ID: 20472200
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rapamycin causes regression of astrocytomas in tuberous sclerosis complex.
    Franz DN; Leonard J; Tudor C; Chuck G; Care M; Sethuraman G; Dinopoulos A; Thomas G; Crone KR
    Ann Neurol; 2006 Mar; 59(3):490-8. PubMed ID: 16453317
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Everolimus treatment of refractory epilepsy in tuberous sclerosis complex.
    Krueger DA; Wilfong AA; Holland-Bouley K; Anderson AE; Agricola K; Tudor C; Mays M; Lopez CM; Kim MO; Franz DN
    Ann Neurol; 2013 Nov; 74(5):679-87. PubMed ID: 23798472
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regression of subependymal giant cell astrocytomas with RAD001 (Everolimus) in tuberous sclerosis complex.
    Yalon M; Ben-Sira L; Constantini S; Toren A
    Childs Nerv Syst; 2011 Jan; 27(1):179-81. PubMed ID: 20703486
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Presurgical Administration of mTOR Inhibitors in Patients with Large Subependymal Giant Cell Astrocytoma Associated with Tuberous Sclerosis Complex.
    Jiang T; Du J; Raynald ; Wang J; Li C
    World Neurosurg; 2017 Nov; 107():1053.e1-1053.e6. PubMed ID: 28866062
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effectiveness and safety of everolimus treatment in patients with tuberous sclerosis complex in real-world clinical practice.
    Cockerell I; Christensen J; Hoei-Hansen CE; Holst L; Grenaa Frederiksen M; Issa-Epe AI; Nedregaard B; Solhoff R; Heimdal K; Johannessen Landmark C; Lund C; Nærland T
    Orphanet J Rare Dis; 2023 Dec; 18(1):377. PubMed ID: 38042867
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Everolimus for tumor recurrence after surgical resection for subependymal giant cell astrocytoma associated with tuberous sclerosis complex.
    Franz DN; Agricola KD; Tudor CA; Krueger DA
    J Child Neurol; 2013 May; 28(5):602-7. PubMed ID: 22805244
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dramatic relapse of seizures after everolimus withdrawal.
    Mingarelli A; Vignoli A; La Briola F; Peron A; Giordano L; Banderali G; Canevini MP
    Eur J Paediatr Neurol; 2018 Jan; 22(1):203-206. PubMed ID: 28888335
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic effect of everolimus on small renal angiomyolipoma in cases of tuberous sclerosis complex-related epilepsy and subependymal giant cell astrocytoma.
    Hatano T; Yuri Y
    Asian J Surg; 2023 Mar; 46(3):1236-1237. PubMed ID: 36031512
    [No Abstract]   [Full Text] [Related]  

  • 31. Cytomorphology of subependymal giant cell astrocytoma.
    Altermatt HJ; Scheithauer BW
    Acta Cytol; 1992; 36(2):171-5. PubMed ID: 1543002
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rapamycin as an alternative to surgical treatment of subependymal giant cell astrocytomas in a patient with tuberous sclerosis complex.
    Birca A; Mercier C; Major P
    J Neurosurg Pediatr; 2010 Oct; 6(4):381-4. PubMed ID: 20887114
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Response to everolimus in patients with giant cell astrocytoma associated to tuberous sclerosis complex].
    Mateos-González ME; López-Laso E; Vicente-Rueda J; Camino-León R; Fernández-Ramos JA; Baena-Gómez MA; Peña-Rosa MJ
    Rev Neurol; 2014 Dec; 59(11):497-502. PubMed ID: 25418144
    [TBL] [Abstract][Full Text] [Related]  

  • 34. mTOR inhibitors in the treatment of subependymal giant-cell astrocytomas associated with tuberous sclerosis.
    Komotar RJ; Starke RM; Connolly ES; Sisti MB
    Neurosurgery; 2011 Apr; 68(4):N24-5. PubMed ID: 21792104
    [No Abstract]   [Full Text] [Related]  

  • 35. EFFECTS: an expanded access program of everolimus for patients with subependymal giant cell astrocytoma associated with tuberous sclerosis complex.
    Fogarasi A; De Waele L; Bartalini G; Jozwiak S; Laforgia N; Verhelst H; Petrak B; Pedespan JM; Witt O; Castellana R; Crippa S; Gislimberti G; Gyorsok Z
    BMC Neurol; 2016 Aug; 16():126. PubMed ID: 27502586
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Successful everolimus therapy for SEGA in pediatric patients with tuberous sclerosis complex.
    Cappellano AM; Senerchia AA; Adolfo F; Paiva PM; Pinho R; Covic A; Cavalheiro S; Saba N
    Childs Nerv Syst; 2013 Dec; 29(12):2301-5. PubMed ID: 23743818
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Everolimus: in patients with subependymal giant cell astrocytoma associated with tuberous sclerosis complex.
    Curran MP
    Paediatr Drugs; 2012 Feb; 14(1):51-60. PubMed ID: 22136276
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacological treatment strategies for subependymal giant cell astrocytoma (SEGA).
    Ebrahimi-Fakhari D; Franz DN
    Expert Opin Pharmacother; 2020 Aug; 21(11):1329-1336. PubMed ID: 32338549
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Subependymal giant cell astrocytoma with tuberous sclerosis--case report.
    Lee WY; Wang YC; Cho DY
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1994 Aug; 10(8):474-8. PubMed ID: 7799469
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Complications of mammalian target of rapamycin inhibitor anticancer treatment among patients with tuberous sclerosis complex are common and occasionally life-threatening.
    Trelinska J; Dachowska I; Kotulska K; Fendler W; Jozwiak S; Mlynarski W
    Anticancer Drugs; 2015 Apr; 26(4):437-42. PubMed ID: 25719621
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.